"The successful audit outcome from USFDA is a reflection of the steady progress that we are making into the mature pharma markets," Bliss GVS Pharma VP-Strategy Business Development Gagan Harsh Sharma said.from Moneycontrol Business News https://ift.tt/2INepwX
No comments:
Post a Comment